Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
The new method relies on methyl groups, small chemical tags attached to DNA that regulate whether genes are on or off. This ...
This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating ...
A newly discovered RNA-based mechanism helps CRISPR systems maintain efficiency by preventing interference, offering insights ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
Morning Overview on MSN
Compact CRISPR tool boosts in-body gene editing to 90% in lab tests
For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...
A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
The document outlines the non-clinical sequencing and bioinformatics data sponsors need to submit as part of INDs and BLAs for gene-editing therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results